Lead-induced neurotoxicity: molecular mechanisms, oxidative stress and emerging pharmacological neuroprotective strategies

Authors

  • Amit Chawla Professor Cum Principal, Faculty of Pharmacy, Tantia University, Sri Ganganagar, Rajasthan, India
  • Sanjay S. Shinde Professor, Faculty of Health Sciences, Department of Nursing, KAAF University, Accra, Ghana
  • Lovesampuranjot Kaur Principal, Faculty of Nursing, Desh Bhagat University, Mandi Gobindgarh, Punjab, India
  • Payal Rani Professor Cum Principal, Mata Jarnail Kaur Memorial College of Pharmacy (Under Desh Bhagat University), Sri Muktsar Sahib, Punjab, India

Abstract

Lead (Pb) is a persistent environmental toxicant that poses a significant threat to human health, particularly because of its adverse effects on the central nervous system (CNS). Both acute and chronic lead exposure can interfere with normal neuronal function, while exposure during prenatal and early postnatal development may produce long-lasting neurological and cognitive abnormalities. Lead-induced neurotoxicity involves multiple interconnected molecular mechanisms, including disruption of calcium homeostasis, altered neurotransmitter signalling, mitochondrial dysfunction, oxidative stress, neuroinflammation and neuronal apoptosis. Among these mechanisms, oxidative stress plays a central role by increasing reactive oxygen species (ROS), reducing endogenous antioxidant defence, promoting lipid peroxidation and damaging cellular proteins and DNA. Lead also interferes with antioxidant enzymes, including superoxide dismutase, catalase and glutathione peroxidase, thereby weakening neuronal resistance to oxidative injury. Conventional management of lead poisoning involves eliminating the exposure source, supportive care and chelation therapy in appropriately selected patients. However, chelation does not reliably reverse established neurological damage. Consequently, increasing attention has been directed towards pharmacological neuroprotective agents, including N-acetylcysteine, vitamins C and E, curcumin, resveratrol, melatonin, alpha-lipoic acid and mitochondria-targeted antioxidants. These compounds have demonstrated antioxidant, anti-inflammatory or antiapoptotic properties in experimental models. Furthermore, modulation of Nrf2/ARE, NF-κB, SIRT1/AMPK and mitochondrial apoptotic pathways represents a promising direction for future drug development. This review critically discusses the molecular mechanisms of lead-induced neurotoxicity, the importance of oxidative stress and the potential of emerging pharmacological interventions. It also identifies limitations in current research and highlights the need for controlled clinical investigations to establish the safety and therapeutic efficacy of experimental neuroprotective agents.

Keywords:

Lead toxicity, neurotoxicity, oxidative stress, reactive oxygen species, mitochondrial dysfunction, neuroinflammation, neuronal apoptosis, antioxidant therapy, chelation therapy, neuroprotection. 

Published

2026-11-03
Statistics
Abstract Display: 1
PDF Downloads: 1

Issue

Section

Articles

How to Cite

Lead-induced neurotoxicity: molecular mechanisms, oxidative stress and emerging pharmacological neuroprotective strategies. (2026). Scienxt Journal of Biopharmaceutics and Pharmacokinetics, 4(1). https://journals.scienxt.com/index.php/sjbp/article/view/291